Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53/mTOR pathway.
Cheng ZhaoZi-Yi YangJian ZhangOu LiShi-Lei LiuChen CaiYi-Jun ShuLi-Jia PanWei GongPing DongPublished in: Journal of translational medicine (2022)
XPO1 may be a promising prognostic indicator for GBC, and KPT-330 appears to be a potential drug for treating GBC effectively and safely.